Breaking up is hard to do RalA, mitochondrial fission and cancer

Small GTPases

Volumn 2, Issue 6, 2011, Pages

  Kashatus, David F ^a   Counter, Christopher M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aurora A; Cell cycle; Mitochondrial fission; Rala; RalBP1

Indexed keywords

AMINO ACID; AURORA A KINASE; RAL PROTEIN; RALA PROTEIN; RALB PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL ACTIVITY; CELL FUNCTION; CELL SURVIVAL; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; METASTASIS; MITOCHONDRIAL FISSION; MITOCHONDRIAL MEMBRANE; NEOPLASM; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM;

EID: 84255186071     PISSN: 21541248     EISSN: 21541256     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49:4682-9.
2. Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 1994; 370:527-32; http://dx.doi.org/10.1038/370527a0
3. Zhang XF, Settleman J, Kyriakis JM, Takeuchi-Suzuki E, Elledge SJ, Marshall MS, et al. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993; 364:308-13; http://dx.doi.org/10.1038/364308a0
4. Han M, Golden A, Han Y, Sternberg PW. C. elegans lin-45 raf gene participates in let-60 ras-stimulated vulval differentiation. Nature 1993; 363:133-40; http://dx.doi.org/10.1038/363133a0
5. Warne PH, Viciana PR, Downward J. Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro. Nature 1993; 364:352-5; http://dx.doi.org/10.1038/364352a0
6. Kyriakis JM, App H, Zhang XF, Banerjee P, Brautigan DL, Rapp UR, et al. Raf-1 activates MAP kinasekinase. Nature 1992; 358:417-21; http://dx.doi.org/10.1038/358417a0
7. Hofer F, Fields S, Schneider C, Martin GS. Activated Ras interacts with the Ral guanine nucleotide dissociation stimulator. Proc Natl Acad Sci USA 1994; 91:11089-93; http://dx.doi.org/10.1073/pnas.91.23.11089
8. Spaargaren M, Bischoff JR. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. Proc Natl Acad Sci USA 1994; 91:12609-13; http://dx.doi.org/10.1073/pnas.91.26.12609
9. Kikuchi A, Demo SD, Ye ZH, Chen YW, Williams LT. ralGDS family members interact with the effector loop of ras p21. Mol Cell Biol 1994; 14:7483-91.
10. Zipfel PA, Brady DC, Kashatus DF, Ancrile BD, Tyler DS, Counter CM. Ral activation promotes melanomagenesis. Oncogene 2010; 29:4859-64; http://dx.doi.org/10.1038/onc.2010.224
11. Martin TD, Samuel JC, Routh ED, Der CJ, Yeh JJ. Activation and involvement of Ral GTPases in colorectal cancer. Cancer Res 2011; 71:206-15; http://dx.doi.org/10.1158/0008-5472.CAN-10-1517
12. Wang H, Owens C, Chandra N, Conaway MR, Brautigan DL, Theodorescu D. Phosphorylation of RalB is important for bladder cancer cell growth and metastasis. Cancer Res 2010; 70:8760-9; http://dx.doi.org/10.1158/0008-5472.CAN-10-0952
13. Lim K-H, Baines AT, Fiordalisi JJ, Shipitsin M, Feig LA, Cox AD, et al. Activation of RalA is critical for Ras-induced tumorigenesis of human cells. Cancer Cell 2005; 7:533-45; http://dx.doi.org/10.1016/j.ccr.2005.04.030
14. Chien Y, White MA. RAL GTPases are linchpin modulators of human tumour-cell proliferation and survival. EMBO Rep 2003; 4:800-6; http://dx.doi.org/10.1038/sj.embor.embor899
15. González-García A, Pritchard CA, Paterson HF, Mavria G, Stamp G, Marshall CJ. RalGDS is required for tumor formation in a model of skin carcinogenesis. Cancer Cell 2005; 7:219-26; http://dx.doi.org/10.1016/j.ccr.2005.01.029
16. Jiménez M, Pérez de Castro I, Benet M, García JF, Inghirami G, Pellicer A. The Rgr oncogene induces tumorigenesis in transgenic mice. Cancer Res 2004; 64:6041-9; http://dx.doi.org/10.1158/0008-5472.CAN-03-3389
17. Bodemann BO, White MA. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat Rev Cancer 2008; 8:133-40; http://dx.doi.org/10.1038/nrc2296
18. Hamad NM, Elconin JH, Karnoub AE, Bai W, Rich JN, Abraham RT, et al. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes Dev 2002; 16:2045-57; http://dx.doi.org/10.1101/gad.993902
19. Neel NF, Martin TD, Stratford JK, Zand TP, Reiner DJ, Der CJ. The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery. Genes Cancer 2011; 2:275-87; http://dx.doi.org/10.1177/1947601911407329
20. Moskalenko S, Henry DO, Rosse C, Mirey G, Camonis JH, White MA. The exocyst is a Ral effector complex. Nat Cell Biol 2002; 4:66-72; http://dx.doi.org/10.1038/ncb728
21. Sugihara K, Asano S, Tanaka K, Iwamatsu A, Okawa K, Ohta Y. The exocyst complex binds the small GTPase RalA to mediate filopodia formation. Nat Cell Biol 2002; 4:73-8; http://dx.doi.org/10.1038/ncb720
22. Moskalenko S, Tong C, Rosse C, Mirey G, Formstecher E, Daviet L, et al. Ral GTPases regulate exocyst assembly through dual subunit interactions. J Biol Chem 2003; 278:51743-8; http://dx.doi.org/10.1074/jbc.M308702200
23. Cantor SB, Urano T, Feig LA. Identification and characterization of Ral-binding protein 1, a potential downstream target of Ral GTPases. Mol Cell Biol 1995; 15:4578-84.
24. Ohta Y, Suzuki N, Nakamura S, Hartwig JH, Stossel TP. The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci USA 1999; 96:2122-8; http://dx.doi.org/10.1073/pnas.96.5.2122
25. Frankel P, Aronheim A, Kavanagh E, Balda MS, Matter K, Bunney TD, et al. RalA interacts with ZONAB in a cell density-dependent manner and regulates its transcriptional activity. EMBO J 2005; 24:54-62; http://dx.doi.org/10.1038/sj.emboj.7600497
26. Chardin P, Tavitian A. Coding sequences of human ralA and ralB cDNAs. Nucleic Acids Res 1989; 17:4380; http://dx.doi.org/10.1093/nar/17.11.4380
27. Lim K-H, O'Hayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol 2006; 16:2385-94; http://dx.doi.org/10.1016/j.cub.2006.10.023
28. Chien Y, Kim S, Bumeister R, Loo YM, Kwon SW, Johnson CL, et al. RalB GTPase-Mediated Activation of the IkappaB Family Kinase TBK1 Couples Innate Immune Signaling to Tumor Cell Survival. Cell 2006; 127:157-70; http://dx.doi.org/10.1016/j.cell.2006.08.034
29. Shipitsin M, Feig LA. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells. Mol Cell Biol 2004; 24:5746-56; http://dx.doi.org/10.1128/MCB.24.13.5746-5756.2004
30. Sablina AA, Chen W, Arroyo JD, Corral L, Hector M, Bulmer SE, et al. The tumor suppressor PP2A Abeta regulates the RalA GTPase. Cell 2007; 129:969-82; http://dx.doi.org/10.1016/j.cell.2007.03.047
31. Wu J-C, Chen T-Y, Yu C-TR, Tsai S-J, Hsu J-M, Tang M-J, et al. Identification of V23RalA-Ser194 as a critical mediator for Aurora-A-induced cellular motility and transformation by small pool expression screening. J Biol Chem 2005; 280:9013-22; http://dx.doi.org/10.1074/jbc.M411068200
32. Bivona TG, Quatela SE, Bodemann BO, Ahearn IM, Soskis MJ, Mor A, et al. PKC regulates a farnesylelectrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell 2006; 21:481-93; http://dx.doi.org/10.1016/j.molcel.2006.01.012
33. Vader G, Lens S. The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 2008; 1786:60-72.
34. Lim K-H, Brady DC, Kashatus DF, Ancrile BB, Der CJ, Cox AD, et al. Aurora-A phosphorylates, activates, and relocalizes the small GTPase RalA. Mol Cell Biol 2010; 30:508-23; http://dx.doi.org/10.1128/MCB.00916-08
35. Kashatus DF, Lim K-H, Brady DC, Pershing NLK, Cox AD, Counter CM. RALA and RALBP1 regulate mitochondrial fission at mitosis. Nat Cell Biol 2011; 13:1-10; http://dx.doi.org/10.1038/ncb2310
36. Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiol Rev 2009; 89:799-845; http://dx.doi.org/10.1152/physrev.00030.2008
37. Otera H, Mihara K. Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem 2011; 149:241-51; http://dx.doi.org/10.1093/jb/mvr002
38. Westermann B. Mitochondrial fusion and fission in cell life and death. Nat Rev Mol Cell Biol 2010; 11:872-84; http://dx.doi.org/10.1038/nrm3013
39. Arakaki N, Nishihama T, Owaki H, Kuramoto Y, Suenaga M, Miyoshi E, et al. Dynamics of mitochondria during the cell cycle. Biol Pharm Bull 2006; 29:1962-5; http://dx.doi.org/10.1248/bpb.29.1962
40. Mitra K, Wunder C, Roysam B, Lin G, Lippincott- Schwartz J. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci USA 2009; 106:11960-5; http://dx.doi.org/10.1073/pnas.0904875106
41. Taguchi N, Ishihara N, Jofuku A, Oka T. Mitotic phosphorylation of dynamin-related GTPase Drp1 participates in mitochondrial fission. J Biol Chem 2007; 282:11521-9; http://dx.doi.org/10.1074/jbc.M607279200
42. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17:3052-65; http://dx.doi.org/10.1093/emboj/17.11.3052
43. Rossé C, L'Hoste S, Offner N, Picard A, Camonis J. RLIP, an effector of the Ral GTPases, is a platform for Cdk1 to phosphorylate epsin during the switch off of endocytosis in mitosis. J Biol Chem 2003; 278:30597-604; http://dx.doi.org/10.1074/jbc.M302191200
44. Fukushige S, Waldman FM, Kimura M, Abe T, Furukawa T, Sunamura M, et al. Frequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma. Genes Chromosomes Cancer 1997; 19:161-9; http://dx.doi.org/10.1002/(SICI)1098-2264(199707)19:3,161::AID-GCC5.3.0.CO;2-W
45. Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, et al. Overexpression of oncogenic STK15/ BTAK/Aurora A kinase in human pancreatic cancer. Clin Cancer Res 2003; 9:991-7.
46. Bodempudi V, Yamoutpoor F, Pan W, Dudek AZ, Esfandyari T, Piedra M, et al. Ral overactivation in malignant peripheral nerve sheath tumors. Mol Cell Biol 2009; 29:3964-74; http://dx.doi.org/10.1128/MCB.01153-08
47. Yu Y, Feig LA. Involvement of R-Ras and Ral GTPases in estrogen-independent proliferation of breast cancer cells. Oncogene 2002; 21:7557-68; http://dx.doi.org/10.1038/sj.onc.1205961
48. Okada T, Sawada T, Osawa T, Adachi M, Kubota K. MK615 inhibits pancreatic cancer cell growth by dual inhibition of Aurora A and B kinases. World J Gastroenterol 2008; 14:1378-82; http://dx.doi.org/10.3748/wjg.14.1378
49. Hata T, Furukawa T, Sunamura M, Egawa S, Motoi F, Ohmura N, et al. RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res 2005; 65:2899-905; http://dx.doi.org/10.1158/0008-5472.CAN-04-3981
50. Vigil D, Martin TD, Williams F, Yeh JJ, Campbell SL, Der CJ. Aberrant overexpression of the Rgl2 Ral small GTPase-specific guanine nucleotide exchange factor promotes pancreatic cancer growth through Raldependent and Ral-independent mechanisms. J Biol Chem 2010; 285:34729-40; http://dx.doi.org/10.1074/jbc.M110.116756
51. Yin J, Pollock C, Tracy K, Chock M, Martin P, Oberst M, et al. Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone. Mol Cell Biol 2007; 27:7538-50; http://dx.doi.org/10.1128/MCB.00955-07
52. Sowalsky AG, Alt-Holland A, Shamis Y, Garlick JA, Feig LA. RalA function in dermal fibroblasts is required for the progression of squamous cell carcinoma of the skin. Cancer Res 2011; 71:758-67; http://dx.doi.org/10.1158/0008-5472.CAN-10-2756
53. Gomes LC, Benedetto GD, Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 2011; 13:589-98; http://dx.doi.org/10.1038/ncb2220
54. Rambold AS, Kostelecky B, Elia N, Lippincott- Schwartz J. Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation. Proc Natl Acad Sci USA 2011; 108:10190-5; http://dx.doi.org/10.1073/pnas.1107402108
55. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev Mol Cell Biol 2011; 12:9-14; http://dx.doi.org/10.1038/nrm3028
56. Chen H, Chan DC. Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 2009; 18:R169-76; http://dx.doi.org/10.1093/hmg/ddp326
57. Sheridan C, Martin SJ. Mitochondrial fission/fusion dynamics and apoptosis. Mitochondrion 2010; 10:640-8; http://dx.doi.org/10.1016/j.mito.2010.08.005
58. Wasilewski M, Scorrano L. The changing shape of mitochondrial apoptosis. Trends Endocrinol Metab 2009; 20:287-94; http://dx.doi.org/10.1016/j.tem.2009.03.007
59. Youle RJ, Karbowski M. Mitochondrial fission in apoptosis. Nat Rev Mol Cell Biol 2005; 6:657-63; http://dx.doi.org/10.1038/nrm1697
60. Campello S, Scorrano L. Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep 2010; 11:678-84; http://dx.doi.org/10.1038/embor.2010.115
61. Parone PA, Da Cruz S, Tondera D, Mattenberger Y, James DI, Maechler P, et al. Preventing mitochondrial fission impairs mitochondrial function and leads to loss of mitochondrial DNA. PLoS ONE 2008; 3:e3257; http://dx.doi.org/10.1371/journal.pone.0003257
62. Wang J-X, Jiao J-Q, Li Q, Long B, Wang K, Liu J-P, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 2011; 17:71-8; http://dx.doi.org/10.1038/nm.2282
63. Arismendi-Morillo G. Electron microscopy morphology of the mitochondrial network in gliomas and their vascular microenvironment. Biochim Biophys Acta 2011; 1807:602-8.
64. Bodemann BO, Orvedahl A, Cheng T, Ram RR, Ou Y-H, Formstecher E, et al. RalB and the exocyst mediate the cellular starvation response by direct activation of autophagosome assembly. Cell 2011; 144:253-67; http://dx.doi.org/10.1016/j.cell.2010.12.018
65. Cox AD. Ras history: The saga continues. Small GTPases 2010; 1:2-27; http://dx.doi.org/10.4161/sgtp.1.1.12178
66. Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, et al. Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax/ Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 2008; 14:193-204; http://dx.doi.org/10.1016/j.devcel.2007.11.019
67. Zorzano A, Sebastián D, Segalés J, Palacín M. The molecular machinery of mitochondrial fusion and fission: An opportunity for drug discovery? Curr Opin Drug Discov Devel 2009; 12:597-606.